Philip Morris International (PM) Financial History
Review Philip Morris International annual and quarterly financial results, key ratios, insider transactions and SEC filing history in one chronological view. Data available from FY2007 through FY2025.
Financials
19 fiscal years, FY2007 to FY2025
Insider trades
346 trades
Risk factor changes
81 changes in the latest 10-K
Filings
Annual and quarterly reports
Compare
Side by side with another company
Philip Morris International Financial Statements
History since FY2007. Annual, in US dollars. Source: 10-K XBRL data.
Philip Morris International Revenue and Growth
Compare reported revenue and year-over-year revenue growth across available fiscal years.
Philip Morris International Income Statements
Review revenue, gross profit, operating income, net income and earnings per share.
Philip Morris International Balance Sheets
Review reported debt and book-value-based ratios where company data is available.
Philip Morris International Cash Flow Statements
Compare reported free cash flow across the available fiscal history.
Philip Morris International Financial Ratios
Compare net margin, price-to-earnings and price-to-book ratios by fiscal year.
| Fiscal year | FY2007 🔒 | FY2008 🔒 | FY2009 🔒 | FY2010 🔒 | FY2011 🔒 | FY2012 🔒 | FY2013 🔒 | FY2014 🔒 | FY2015 🔒 | FY2016 🔒 | FY2017 🔒 | FY2018 🔒 | FY2019 🔒 | FY2020 🔒 | FY2021 | FY2022 | FY202320 new risk factorsInsiders net sold $17.2M | FY2024 | FY202518 new risk factorsInsiders net sold $25.0M |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $82.2B | $80.7B | $35.2B | $37.9B | $40.6B |
| Revenue growth | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | — | -1.9% | -56.4% | +7.7% | +7.3% |
| Gross profit | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $21.4B | $20.4B | $22.3B | $24.5B | $27.3B |
| Operating income | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $13.0B | $12.2B | $11.6B | $13.4B | $14.9B |
| Net income | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $9.1B | $9.0B | $7.8B | $7.1B | $11.3B |
| Debt | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $27.8B | $43.1B | $47.9B | $45.7B | $48.8B |
| Free cash flow | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $11.2B | $9.7B | $7.9B | $10.8B | $10.7B |
| Net margin | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | 11.1% | 11.2% | 22.2% | 18.6% | 27.9% |
| EPS (diluted) | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $5.83 | $5.81 | $5.02 | $4.52 | $7.26 |
| P/E ratio | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | 16.3× | 17.4× | 18.8× | 26.6× | 22.1× |
| P/B ratio | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | — | — | — | — | — |
Daily closing prices, aggregated by calendar year.
| Year | 2008 🔒 | 2009 🔒 | 2010 🔒 | 2011 🔒 | 2012 🔒 | 2013 🔒 | 2014 🔒 | 2015 🔒 | 2016 🔒 | 2017 🔒 | 2018 🔒 | 2019 🔒 | 2020 🔒 | 2021 🔒 | 2022 | 2023 | 2024 | 2025 | 2026 (YTD) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Open | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $94.95 | $101.70 | $93.84 | $121.16 | $160.21 |
| Close | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $101.21 | $94.14 | $120.33 | $160.45 | $201.44 |
| High | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $112.47 | $105.62 | $134.15 | $186.66 | $215.64 |
| Low | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $82.85 | $87.24 | $87.83 | $116.14 | $151.69 |
| Annual return | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | +6.5% | -7.0% | +27.8% | +33.3% | +25.5% |
Philip Morris International Insider Transactions
From Form 4 filings. Showing the latest 5 of 346 trades.
| Traded | Filed | Insider | Type | Shares | Value | % of holdings |
|---|---|---|---|---|---|---|
| 2026-05-06 | 2026-05-08 | Michel Combes Director | Grant or award | 1,119 | $190K | — |
| 2026-05-06 | 2026-05-08 | Werner Geissler Director | Grant or award | 1,119 | $190K | — |
| 2026-05-06 | 2026-05-08 | Kalpana Morparia Director | Grant or award | 1,119 | $190K | — |
| 2026-05-06 | 2026-05-08 | Victoria Harker Director | Grant or award | 1,119 | $190K | — |
| 2026-05-06 | 2026-05-08 | Robert Polet Director | Grant or award | 1,119 | $190K | — |
Philip Morris International Risk Factor Changes
Latest 10-K compared with the year before. 81 changes found.
An actual or alleged failure to comply with complex and changing privacy, data, artificial intelligence and information security laws and regulations such as under the EU General Data Protection Regulation, various U.S.
We and our business partners heavily rely on information technology networks and systems, including those connected to the Internet, to help manage business processes and operations, including the collection, storage,…
Risks Related to Cybersecurity, Data Governance and Artificial Intelligence
Our Wellness business is researching and developing medical and pharmaceutical cannabinoids and non-recreational cannabinoid products (including CBD).
Inflationary pressures have and may continue to result in significant increases to our expenses, including direct materials, wages, energy, transportation, and logistics costs.
Some of the countries in which we operate face the threat of civil unrest and can be subject to regime changes.
A prolonged disruption at or shut-down of one or more of the facilities where our products or product components are produced, or sourced from, especially our ZYN production facility in Kentucky, U.S., which currently…
A prolonged disruption of facilities used to produce our products could have a material adverse effect on our business, financial condition and results of operations.
Furthermore, there is a continued and, in some cases, increased focus by certain regulatory and legislative bodies on environmental policies, including by the governmental authorities in certain international jurisdic…
Risks related to the natural environment and related legal or regulatory developments may have a negative impact on our business and results of operations.
Risks Related to Sourcing, Distribution and Quality of Products, Services and Materials
The conflict also continues to elevate the likelihood of supply chain disruptions, both in the region and globally, and may inhibit our ability to timely source materials and services needed to make and sell our produ…
The full implications of the Russian invasion of Ukraine for our operations in those countries are impossible to predict at this time.
Unstable geopolitical conditions or events in certain markets, including international conflicts, civil unrest, acts of war, terrorism, governmental changes, or changes in international relations could result in negat…
We are subject to income tax laws in the United States and numerous foreign jurisdictions.
To date, we have been largely successful in demonstrating to regulators that our SFPs are not cigarettes due to the absence of combustion, and accordingly they are frequently taxed either as a separate category or as…
manufactured by certain of our competitors.
To be successful, we must continue evolving our culture and ways of working, align our talent and organizational design with our increasingly complex business needs, and innovate and transform to a consumer-centric bu…
In addition to our consolidated financial results, our management regularly reviews a number of operating, performance, risk, and financial metrics, including various revenue, user and sales metrics (such as market sh…
We are subject to highly competitive conditions in all aspects of our business.
Federal, state or local government action, including regulatory actions and inaction by the FDA, may have a material adverse impact on our commercialization of SFPs and in our business in the United States.
increased restrictions on smoking and use of tobacco and nicotine-containing products in public or private spaces, both indoors or outdoors;
disclosure, restrictions, or bans of tobacco and nicotine-containing product ingredients, components or other product features, including bans on the flavors of certain tobacco and nicotine-containing products, and re…
Governmental actions to restrict or entirely prohibit the use of certain SFP categories have also been considered or adopted in various jurisdictions.
Our business faces significant governmental actions aimed at increasing regulatory requirements with the goal of reducing or preventing the use of tobacco or nicotine-containing products.
Our SFPs and commercial activities for these products are designed for, and directed toward, current adult smokers and adult users of nicotine-containing products.
marketing of e-vapor products to youth, as well as alleged health consequences associated with the use of certain SFPs, may unfavorably impact public opinion and/or mischaracterize the health consequences of our SFPs…
We cannot guarantee that any forward-looking statement will be realized, although we believe we have been prudent in our plans and assumptions.
Given the nature of assets acquired through acquisitions, we may not be able to avoid future impairments of those assets, which may also have a material adverse impact on our future operating results and financial pos…
Accounting adjustments related to acquisitions could adversely affect our financial results.
liability insurance policy to address many of these risks, such policy may not be sufficient to prevent a cybersecurity incident or attack from resulting in a material adverse effect on our business, reputation, finan…
Our or our business partners’ failure or inability to adhere to privacy, data, artificial intelligence and information security laws could result in business disruption, loss of reputation and consumer trust, litigati…
Our safeguards may not, however, be effective in mitigating the impact of service disruptions or other failures of these information technology networks and systems.
We continue to make investments in administrative, technical, and physical safeguards to maintain information security protections in line with industry standards and best practices.
One element of our growth strategy is to expand our brand portfolio and market positions through selective acquisitions and the development of strategic business relationships.
We may be unable to expand our brand portfolio through acquisitions or the development of strategic business relationships, and the intended benefits from our investments may not materialize.
In periods of economic uncertainty, adult consumers may tend to purchase low-price brands, and the volume of our premium-price and mid-price brands and our profitability could be materially adversely impacted as a res…
be able to protect or enhance margins through price increases.
ensure adequate production capacity to meet demand for our products; and
mitigate the impact of developments that cause damage to our reputation and that of our brands;
ensure effective adult consumer engagement, including communication about product characteristics and usage of SFPs;
educate and encourage adult smokers to convert to our SFPs;
develop new products and markets and broaden brand portfolios;
ensure that our products meet our quality standards;
anticipate and respond to new adult consumer trends;
Our business is subject to changes in adult consumer preferences, which may be influenced by local economic conditions, accessibility to our products and availability of accurate information related to our products.
Competitors in our industry include Altria Group, Inc., British American Tobacco plc, Japan Tobacco Inc., Imperial Brands plc, new market entrants, particularly with respect to innovative products, several regional an…
Risks Related to our Competitive Environment
Furthermore, nature-related risks, including those related to natural ecosystems degradation, decreased agricultural productivity in certain regions of the world, biodiversity loss, water resource depletion and defore…
While we seek to mitigate our business risks associated with environmental issues, such as climate change, by establishing environmental goals and standards and seeking business partners, including within our supply c…
In 2024, Russia accounted for around 9% of our total cigarette and heated tobacco unit shipment volume, and around 6% of our total net revenues.
that, while presented with numerical specificity, are inherently subject to significant uncertainties and contingencies.
We are subject to income tax laws in the United States and numerous foreign jurisdictions.
Governmental actions, combined with the diminishing social acceptance of smoking and private actions to restrict smoking, have resulted in reduced industry volumes for our products in many of our markets, and we expec…
Moreover, we also submitted additional premarket tobacco applications for other ZYN products after the September 9, 2020 deadline, and we are unable to market these products until the FDA authorizes such applications.
products or competitive products among youth or non-smokers, even in situations over which we have no control, our reputation and credibility may suffer, the regulatory approach to our products may become more restric…
The World Health Organization (the "WHO") study group on tobacco product regulation published their ninth report on the scientific basis of tobacco product regulation in August 2023.
advocate for the development of science-based regulatory frameworks for the development and commercialization of SFPs, including the communication of scientifically substantiated information to enable adult smokers to…
substantiate the reduction of risk for the individual adult smoker and the reduction of harm to the population as a whole, based on scientific evidence of the highest standard that is made available for scrutiny and r…
for those adult smokers, our goal is to develop and offer SFPs with a scientifically substantiated risk-reduction profile that approaches as closely as possible the risk-reduction profile associated with smoking cessa…
develop SFPs that adult smokers who would otherwise continue to smoke cigarettes find to be satisfying alternatives to smoking;
Our key strategic priorities are to: (i) continue developing and commercializing products that present less risk of harm to adult smokers who switch to smoke-free products versus continued cigarette smoking; and (ii)…
should not consider the following to be a complete discussion of all potential risks or uncertainties.
networks and systems and the integrity, availability, security, or privacy of PMI data processed by or through such systems.
We and our business partners are increasingly incorporating artificial intelligence ("AI")-based solutions in our ways of working and operations, but this process involves uncertainty and risks, which may or may not y…
We increasingly use artificial intelligence-based solutions in our business, which could result in reputational harm, legal liability, and adversely affect our operating results.
Our or our business partners’ failure or inability to adhere to privacy, data, artificial intelligence and information security laws could result in reputational harm, legal liability, and adversely affect our operati…
revenue; and result in significant expense to repair or replace affected facilities.
Additionally, we source the vast majority of our tobacco from a global network of farmers across multiple countries, rather than through commodity markets, which helps ensure the consistency, quality, and traceability…
While we seek to mitigate the physical risks to our business associated with the natural environment through a comprehensive strategy that includes the development and implementation of robust mitigation and adaptatio…
Additionally, we expect that these third parties adhere to our applicable standards and to applicable laws related to product quality, responsible marketing, data protection, labor practices, and other areas.
In 2025, Russia accounted for around 9% of our total cigarette and heated tobacco unit shipment volume, and around 6% of our total net revenues.
Tax regimes, including excise taxes, sales taxes and import duties, can disproportionately affect the retail price of cigarettes versus other combustible tobacco products, or disproportionately affect the relative ret…
Our business is subject to changes in adult consumer preferences and if we do not accurately assess market trends, are unable to adapt our product offerings to evolving consumer demands, or face challenges in product…
appropriate R&D protocols and standards, all of which could have a material adverse effect on our profitability and results of operations.
Some of our competitors have different profit, volume and regulatory objectives, some international competitors may be less susceptible than PMI to changes in currency exchange rates, and some competitors may sell pro…
The success of our business in the United States is dependent on an evolving legal and regulatory framework.
Classification of the product as food such that any nicotine amounts beyond de minimis content de facto bans the nicotine product from the market
We anticipate that significant regulatory restrictions will continue to be considered and adopted in many markets.
Governmental actions, combined with the diminishing social acceptance of smoking and private actions to restrict smoking, have resulted in reduced industry volumes for our combustible products in many of our markets,…
Our strategic priority is the continued introduction, commercialization, and growth of our SFPs and if these efforts are not successful, in key markets or systematically, our financial results and future growth prospe…
Philip Morris International SEC Filings
Latest annual and quarterly reports, current reports, proxy statements and ownership filings.
| Form | Filed | Description | Document |
|---|---|---|---|
| Quarterly report (10-Q) | 2026-10-23 | Quarter ended Sep 30, 2026 | View document |
| Current report (8-K) | 2026-10-21 | Quarterly results | View document |
| Current report (8-K) | 2026-09-18 | Company update | View document |
| Current report (8-K) | 2026-09-08 | Company update | View document |
| Current report (8-K) | 2026-09-08 | Company update | View document |
Philip Morris International financial metrics by year
Philip Morris International in the S&P 500 rankings
- #93 by revenue as of FY2025
- #32 by net income as of FY2025
- #58 by net profit margin as of FY2025
- #24 by operating income as of FY2025
- #33 by free cash flow as of FY2025
S&P 500 is a trademark of S&P Dow Jones Indices LLC. StockYears is not affiliated with or endorsed by S&P Dow Jones Indices.
Compare Philip Morris International with similar companies
- PM vs MO Altria Group